Improved anti-tumor vaccination activity of necroptotic cells lacking ATG16L1-dependent unconventional autophagy
- 1Center for Molecular Biology, Madrid, Spain
Abstract
Immunogenic forms of tumor cell death can induce effective anti-cancer immune responses, but the molecular mechanisms that regulate the immunogenic potential of cell suicide and how they shape anti-tumor immunity in vivo are issues that remain to be fully elucidated. Here we show that absence of unconventional autophagy mediated by the WD40 domain (WDD) of ATG16L1 increases the anti-tumor vaccinating capacity of dying cells. Necroptotic mouse carcinoma MC38 cells lacking the WDD fail to mount a concomitant unconventional autophagic response and exhibit superior vaccinating capacity against MC38 tumors inoculated afterwards. The mutant strain secretes higher levels of ATP during cell demise, whereas other Damage-Associated Molecular Patterns (DAMPs) remain unaffected. The vaccinating effect is accompanied by increased tumor immune infiltration, depends on secreted ATP and requires T cells. These results indicate that suppression of ATG16L1-mediated unconventional autophagy during tumor cell death improves anti-tumor immunity, and identify this process as a potential therapeutic target to enhance the immune contribution to control tumor development.
Related
- Advancing Tuberculosis Vaccination: Immunological Insights and Emerging Strategies for Improved Protection.
- UCHL5 stabilizes ALK5 to promote autophagy dependent ferroptosis in osteoarthritis
- TRIM14 recruits BRCC3 to stabilize PD-L1 by suppressing p62-dependent selective autophagy in glioma
- Knockdown of Smurf1 Promotes Autophagy-Dependent Ferroptosis in Acute Liver Failure by Inhibiting Ubiquitin-Mediated Ulk1 Degradation.
- A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease
BibTeX
@misc{banderalinero2026improved,
title = {{Improved anti-tumor vaccination activity of necroptotic cells lacking ATG16L1-dependent unconventional autophagy}},
author = {J. Bandera-Linero and D. Ona-Sanchez and K. Stamatakis and F. X. Pimentel-Muinos},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.16.759377},
url = {https://www.biorxiv.org/content/10.64898/2026.10.16.759377v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Improved anti-tumor vaccination activity of necroptotic cells lacking ATG16L1-dependent unconventional autophagy
AU - J. Bandera-Linero
AU - D. Ona-Sanchez
AU - K. Stamatakis
AU - F. X. Pimentel-Muinos
PY - 2026
DA - 2026/10/16
PB - bioRxiv
DO - 10.64898/2026.10.16.759377
UR - https://www.biorxiv.org/content/10.64898/2026.10.16.759377v1
AB - Immunogenic forms of tumor cell death can induce effective anti-cancer immune responses, but the molecular mechanisms that regulate the immunogenic potential of cell suicide and how they shape anti-tumor immunity in vivo are issues that remain to be fully elucidated. Here we show that absence of unconventional autophagy mediated by the WD40 domain (WDD) of ATG16L1 increases the anti-tumor vaccinating capacity of dying cells. Necroptotic mouse carcinoma MC38 cells lacking the WDD fail to mount a concomitant unconventional autophagic response and exhibit superior vaccinating capacity against MC38 tumors inoculated afterwards. The mutant strain secretes higher levels of ATP during cell demise, whereas other Damage-Associated Molecular Patterns (DAMPs) remain unaffected. The vaccinating effect is accompanied by increased tumor immune infiltration, depends on secreted ATP and requires T cells. These results indicate that suppression of ATG16L1-mediated unconventional autophagy during tumor cell death improves anti-tumor immunity, and identify this process as a potential therapeutic target to enhance the immune contribution to control tumor development.
ER -